Dr. Covelli (CMO), Dr. Elia, Dr. Ravenni, and Dr. Nadal will participate at the event in Rome.

The dermato-oncology team from St. Gallen will give a presentation entitled “Intralesional administration of L19IL2/L19TNF in difficult-to-treat BCC patients shows favorable safety profile and leads to complete remission of tumor lesions”

Moreover, Prof. Dario Neri, CEO and CSO of Philogen, is giving a presentation on the 21st of April 2023 entitled “Innovative targeted therapies in Oncology and beyond”.

Please follow the link for more information.